• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

100例亨廷顿舞蹈症患者神经病理学严重程度的预测因素

Predictors of neuropathological severity in 100 patients with Huntington's disease.

作者信息

Rosenblatt Adam, Abbott Margaret H, Gourley Lisa M, Troncoso Juan C, Margolis Russell L, Brandt Jason, Ross Christopher A

机构信息

Department of Psychiatry, Johns Hopkins University School of Medicine, Meyer 2-181, 600 North Wolfe Street, Baltimore, MD 21287, USA.

出版信息

Ann Neurol. 2003 Oct;54(4):488-93. doi: 10.1002/ana.10691.

DOI:10.1002/ana.10691
PMID:14520661
Abstract

Subjects were followed in the Longitudinal Core Study of the Baltimore Huntington's Disease Center and given annual neurological, cognitive, and psychiatric examinations. Postmortem neuropathological grade was assigned using the system of Vonsattel and colleagues. We examined the correlations between the neuropathological grade and scores on the Quantified Neurological Examination (QNE) and its chorea and motor impairment subscales, the Mini-Mental State Examination (MMSE), the HD Activities of Daily Living (ADL) Scale, and a number of demographic variables (CAG number, age of onset, age at death, disease duration) in 100 subjects who had been examined within 1,000 days of death. All measures showed significant correlation with Vonsattel score except for chorea. The strongest effect was that of motor impairment score (r(2) = 0.351, p < 0.0001). In a stepwise correlation of clinical variables, motor impairment remained significant. The largest effect for a demographic variable was for age of onset (r(2) = 0.226, p < 0.0001) A partial correlation was significant between CAG number and Vonsattel grade, controlling for age at death or disease duration. Motor impairment appears to be a good clinical measure of neuronal cell loss, at least late in the course of HD and therefore may prove useful in observational and treatment studies.

摘要

研究对象参与了巴尔的摩亨廷顿舞蹈病中心的纵向核心研究,并接受了年度神经学、认知和精神检查。死后神经病理学分级采用冯·萨特尔及其同事的系统进行评定。我们在100名在死亡前1000天内接受检查的受试者中,研究了神经病理学分级与定量神经学检查(QNE)及其舞蹈症和运动障碍分量表、简易精神状态检查表(MMSE)、亨廷顿舞蹈病日常生活活动(ADL)量表得分以及一些人口统计学变量(CAG重复数、发病年龄、死亡年龄、病程)之间的相关性。除舞蹈症外,所有测量指标均与冯·萨特尔评分显示出显著相关性。最强的影响因素是运动障碍评分(r(2)=0.351,p<0.0001)。在临床变量的逐步相关性分析中,运动障碍仍然具有显著性。对于人口统计学变量,最大的影响因素是发病年龄(r(2)=0.226,p<0.0001)。在控制死亡年龄或病程的情况下,CAG重复数与冯·萨特尔分级之间的偏相关性显著。运动障碍似乎是神经元细胞丢失的一个良好临床指标,至少在亨廷顿舞蹈病病程后期如此,因此可能在观察性研究和治疗研究中有用。

相似文献

1
Predictors of neuropathological severity in 100 patients with Huntington's disease.100例亨廷顿舞蹈症患者神经病理学严重程度的预测因素
Ann Neurol. 2003 Oct;54(4):488-93. doi: 10.1002/ana.10691.
2
The association of CAG repeat length with clinical progression in Huntington disease.亨廷顿病中CAG重复序列长度与临床进展的关联。
Neurology. 2006 Apr 11;66(7):1016-20. doi: 10.1212/01.wnl.0000204230.16619.d9.
3
Factors contributing to institutionalization in patients with Huntington's disease.导致亨廷顿病患者住院的因素。
Mov Disord. 2011 Aug 1;26(9):1711-6. doi: 10.1002/mds.23716. Epub 2011 Apr 29.
4
Assessment of adaptive functioning in Huntington's disease.亨廷顿舞蹈症的适应性功能评估。
Mov Disord. 1993 Apr;8(2):183-90. doi: 10.1002/mds.870080212.
5
Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.亨廷顿舞蹈病中三核苷酸重复序列与神经病理学变化之间的关系。
Ann Neurol. 1996 Jan;39(1):132-6. doi: 10.1002/ana.410390120.
6
Unified Huntington's disease rating scale: a follow up.统一亨廷顿病评定量表:随访
Mov Disord. 1998 Nov;13(6):915-9. doi: 10.1002/mds.870130609.
7
Unified Huntington's disease rating scale: clinical practice and a critical approach.统一亨廷顿舞蹈病评定量表:临床实践与批判性方法
Funct Neurol. 2006 Oct-Dec;21(4):217-21.
8
Functional decline in Huntington's disease.亨廷顿舞蹈症中的功能衰退
Mov Disord. 1995 Mar;10(2):211-4. doi: 10.1002/mds.870100213.
9
Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.亨廷顿舞蹈症患者及其高危亲属的认知与精神特征
Neurol Sci. 2002 Sep;23 Suppl 2:S105-6. doi: 10.1007/s100720200091.
10
Postural deficits in Huntington's disease when performing motor skills involved in daily living.亨廷顿病患者在进行日常活动相关运动技能时存在姿势缺陷。
Gait Posture. 2011 Mar;33(3):457-61. doi: 10.1016/j.gaitpost.2010.12.025. Epub 2011 Jan 20.

引用本文的文献

1
Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington's Disease.基因代理的HMG-CoA还原酶抑制与亨廷顿舞蹈病发病年龄之间的关联
Brain Sci. 2022 Nov 15;12(11):1551. doi: 10.3390/brainsci12111551.
2
Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington's Disease.运动对亨廷顿病骨骼肌病理生理学的影响
J Funct Morphol Kinesiol. 2022 May 11;7(2):40. doi: 10.3390/jfmk7020040.
3
Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease.
亨廷顿蛋白中的聚谷氨酰胺扩展与亨廷顿病中DNA损伤修复缺陷的机制
Front Cell Neurosci. 2022 Apr 4;16:837576. doi: 10.3389/fncel.2022.837576. eCollection 2022.
4
Uncoupling the Excitatory Amino Acid Transporter 2 From Its C-Terminal Interactome Restores Synaptic Glutamate Clearance at Corticostriatal Synapses and Alleviates Mutant Huntingtin-Induced Hypokinesia.将兴奋性氨基酸转运体2与其C末端相互作用组解偶联可恢复皮质纹状体突触处的突触谷氨酸清除,并减轻突变型亨廷顿蛋白诱导的运动减退。
Front Cell Neurosci. 2022 Jan 31;15:792652. doi: 10.3389/fncel.2021.792652. eCollection 2021.
5
Epigenomic Remodeling in Huntington's Disease-Master or Servant?亨廷顿舞蹈病中的表观基因组重塑:主因还是从属因素?
Epigenomes. 2020 Jul 31;4(3):15. doi: 10.3390/epigenomes4030015.
6
Site-Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases.通过发现新型激酶,实现亨廷顿外显子 1 重组蛋白的定点磷酸化。
Chembiochem. 2021 Jan 5;22(1):217-231. doi: 10.1002/cbic.202000508. Epub 2020 Oct 13.
7
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life Planning.亨廷顿病的终末期治疗措施:HDQLIFE 的意义和目的、对死亡和临终的关注以及终末期治疗计划。
J Neurol. 2019 Oct;266(10):2406-2422. doi: 10.1007/s00415-019-09417-7. Epub 2019 Jun 12.
8
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.亨廷顿舞蹈病运动症状和体征的评定量表:批判与建议
Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.
9
Developmental Whole Brain White Matter Alterations in Transgenic Huntington's Disease Monkey.转基因亨廷顿病猴全脑白质发育改变。
Sci Rep. 2017 Mar 23;7(1):379. doi: 10.1038/s41598-017-00381-8.
10
Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.了解亨廷顿病药物试验中使用的疗效指标:一项系统综述。
J Huntingtons Dis. 2014;3(3):233-52. doi: 10.3233/JHD-140115.